de Jong PE - Search Results

1

Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.

Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, Gans RO, Struck J, Schulte J, Hillege HL, van der Harst P, Peelen LM, Beulens JW, Stolk RP, Navis G, Bakker SJ. Abbasi A, et al. Among authors: de jong pe. J Am Heart Assoc. 2012 Oct;1(5):e002956. doi: 10.1161/JAHA.112.002956. Epub 2012 Oct 25. J Am Heart Assoc. 2012. PMID: 23316297 Free PMC article.

2

Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population.

Oterdoom LH, Gansevoort RT, Schouten JP, de Jong PE, Gans RO, Bakker SJ. Oterdoom LH, et al. Among authors: de jong pe. Atherosclerosis. 2009 Dec;207(2):534-40. doi: 10.1016/j.atherosclerosis.2009.05.010. Epub 2009 May 21. Atherosclerosis. 2009. PMID: 19535078

3

N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.

Linssen GC, Bakker SJ, Voors AA, Gansevoort RT, Hillege HL, de Jong PE, van Veldhuisen DJ, Gans RO, de Zeeuw D. Linssen GC, et al. Among authors: de jong pe, de zeeuw d. Eur Heart J. 2010 Jan;31(1):120-7. doi: 10.1093/eurheartj/ehp420. Epub 2009 Oct 23. Eur Heart J. 2010. PMID: 19854731

4

Influence of age and measure of eGFR on the association between renal function and cardiovascular events.

van der Velde M, Bakker SJ, de Jong PE, Gansevoort RT. van der Velde M, et al. Among authors: de jong pe. Clin J Am Soc Nephrol. 2010 Nov;5(11):2053-9. doi: 10.2215/CJN.08851209. Epub 2010 Aug 12. Clin J Am Soc Nephrol. 2010. PMID: 20705964 Free PMC article.

5

External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study.

Abbasi A, Corpeleijn E, Peelen LM, Gansevoort RT, de Jong PE, Gans RO, Rathmann W, Kowall B, Meisinger C, Hillege HL, Stolk RP, Navis G, Beulens JW, Bakker SJ. Abbasi A, et al. Among authors: de jong pe. Eur J Epidemiol. 2012 Jan;27(1):47-52. doi: 10.1007/s10654-011-9648-4. Epub 2012 Jan 4. Eur J Epidemiol. 2012. PMID: 22215562 Free article.

6

Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.

Brouwers FP, de Boer RA, van der Harst P, Struck J, de Jong PE, de Zeeuw D, Gans RO, Gansevoort RT, Hillege HL, van Gilst WH, Bakker SJ. Brouwers FP, et al. Among authors: de boer ra, de jong pe, de zeeuw d. Heart. 2012 Sep;98(18):1348-53. doi: 10.1136/heartjnl-2012-302390. Epub 2012 Jul 21. Heart. 2012. PMID: 22821276

7

Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.

Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, Bakker SJ, de Zeeuw D. Smink PA, et al. Among authors: de jong pe, de zeeuw d. Am J Kidney Dis. 2012 Nov;60(5):804-11. doi: 10.1053/j.ajkd.2012.06.017. Epub 2012 Jul 25. Am J Kidney Dis. 2012. PMID: 22835901

8

Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.

Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Hillege HL, et al. Among authors: de jong pe, de zeeuw d. Circulation. 2002 Oct 1;106(14):1777-82. doi: 10.1161/01.cir.0000031732.78052.81. Circulation. 2002. PMID: 12356629

9

C-reactive protein is associated with renal function abnormalities in a non-diabetic population.

Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. Stuveling EM, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 2003 Feb;63(2):654-61. doi: 10.1046/j.1523-1755.2003.00762.x. Kidney Int. 2003. PMID: 12631131 Free article.

10

C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease.

Stuveling EM, Hillege HL, Bakker SJ, Asselbergs FW, de Jong PE, Gans RO, de Zeeuw D; PREVEND study group. Stuveling EM, et al. Among authors: de jong pe, de zeeuw d. Atherosclerosis. 2004 Jan;172(1):107-14. doi: 10.1016/s0021-9150(03)00252-1. Atherosclerosis. 2004. PMID: 14709363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters